Assenagon Asset Management S.A. Rocket Pharmaceuticals, Inc. Transaction History

Assenagon Asset Management S.A.

$47.8 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	SELL	$20.66 - $26.72 $1.05 Million - $1.36 Million	-50,740 Reduced 62.85%	29,986 $645,000
Q1 2024 Apr 24, 2024	SELL	$26.16 - $30.74 $16.3 Million - $19.1 Million	-621,899 Reduced 88.51%	80,726 $2.17 Million
Q4 2023 Jan 17, 2024	SELL	$16.78 - $31.94 $2.93 Million - $5.57 Million	-174,515 Reduced 19.9%	702,625 $21.1 Million
Q3 2023 Nov 06, 2023	BUY	$15.07 - $24.05 $6.78 Million - $10.8 Million	449,569 Added 105.14%	877,140 $18 Million
Q2 2023 Jul 25, 2023	SELL	$16.59 - $23.6 $83,232 - $118,401	-5,017 Reduced 1.16%	427,571 $8.5 Million
Q1 2023 Apr 18, 2023	SELL	$15.79 - $22.6 $9.04 Million - $12.9 Million	-572,734 Reduced 56.97%	432,588 $7.41 Million
Q4 2022 Jan 12, 2023	SELL	$15.5 - $22.76 $5.88 Million - $8.64 Million	-379,612 Reduced 27.41%	1,005,322 $19.7 Million
Q3 2022 Oct 27, 2022	SELL	$12.37 - $18.41 $3.82 Million - $5.69 Million	-308,828 Reduced 18.23%	1,384,934 $22.1 Million
Q2 2022 Jul 27, 2022	BUY	$7.96 - $16.64 $2.97 Million - $6.21 Million	373,201 Added 28.26%	1,693,762 $23.3 Million
Q1 2022 Apr 25, 2022	BUY	$13.16 - $23.68 $10.3 Million - $18.6 Million	783,621 Added 145.94%	1,320,561 $20.9 Million
Q4 2021 Feb 01, 2022	BUY	$21.52 - $36.02 $10.9 Million - $18.3 Million	507,588 Added 1729.31%	536,940 $11.7 Million
Q3 2021 Oct 19, 2021	SELL	$27.42 - $48.97 $174,363 - $311,400	-6,359 Reduced 17.81%	29,352 $877,000
Q2 2021 Jul 15, 2021	SELL	$39.41 - $47.25 $6,345 - $7,607	-161 Reduced 0.45%	35,711 $1.58 Million
Q1 2021 Apr 26, 2021	SELL	$43.34 - $65.91 $365,269 - $555,489	-8,428 Reduced 19.02%	35,872 $1.59 Million
Q4 2020 Feb 01, 2021	SELL	$23.3 - $59.57 $7 Million - $17.9 Million	-300,429 Reduced 87.15%	44,300 $2.43 Million
Q3 2020 Oct 07, 2020	SELL	$20.5 - $28.59 $3.03 Million - $4.22 Million	-147,637 Reduced 29.99%	344,729 $7.88 Million
Q2 2020 Jul 21, 2020	BUY	$13.32 - $22.61 $6.56 Million - $11.1 Million	492,366 New	492,366 $10.3 Million
Q3 2019 Oct 16, 2019	SELL	$10.85 - $14.78 $2.5 Million - $3.4 Million	-230,342 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$15.0 - $19.81 $2.56 Million - $3.38 Million	170,775 Added 286.69%	230,342 $3.46 Million
Q1 2019 Apr 26, 2019	BUY	$13.45 - $19.01 $201,225 - $284,408	14,961 Added 33.54%	59,567 $1.05 Million
Q4 2018 Jan 23, 2019	BUY	$11.21 - $23.53 $500,033 - $1.05 Million	44,606 New	44,606 $661,000

Others Institutions Holding RCKT

# of Institutions

209

Shares Held

93.2M

Call Options Held

319K

Put Options Held

70.3K

Rtw Investments, LP New York, NY

17.7M
Shares

$231 Million
5.21% of portfolio
Wellington Management Group LLP Boston, MA

11.2M
Shares

$147 Million
0.04% of portfolio
Black Rock Inc. New York, NY

6.19M
Shares

$80.8 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

5.54M
Shares

$72.2 Million
0.0% of portfolio
Westfield Capital Management CO LP Boston, MA

4.49M
Shares

$58.6 Million
0.39% of portfolio

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $987M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.

Account